GSK plc (GSK) Form 6-K — Sep 22, 2026

GSK plc filed a Form 6-K on September 22, 2026 containing PDMR transaction notifications for eight directors and board members. On September 18, 2026, Non-Executive Chair Sir Jonathan Symonds purchased 1,500 GSK ordinary shares at £18.8110 on the London Stock Exchange, and Roy Jackobs purchased 936 ordinary shares at £18.8100. Six independent and senior independent non-executive directors, including Charles Bancroft, Liz McKee Anderson, Anne Beal, Hal Dietz, Jeannie Lee, and Vishal Sikka, purchased American Depositary Shares at $49.8534 on the NYSE, totaling roughly 5,412 ADSs.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.